An idea whose time has come? An African foresight observatory on genomics medicine and data-intensive global science

Current Pharmacogenomics and Personalized Medicine

Volumn 10, Issue 1, 2012, Pages 7-15

  Dandara, Collet ^a   Adebamowo, Clement ^b,c,l   de Vries, Jantina ^a   Dove, Edward S ^d   Fisher, Erik ^e   Gibbs, Richard A ^f   Hotez, Peter J ^f   Kickbusch, Ilona ^g   Knoppers, Bartha M ^d,h   Masellis, Mario ⁱ   Oestergaard, Mikkel Z ^j   Pang, Tikki ^j   Rotimi, Charles N ^k  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e ARIZONA STATE UNIVERSITY   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g GRADUATE INSTITUTE OF INTERNATIONAL AND DEVELOPMENT STUDIES   (Switzerland)

^h Public Population Project in Genomics P3G   (Canada)

ⁱ Sunnybrook Health Sciences Centre   (Canada)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

^k NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^l UNIVERSITY OF MARYLAND   (United States)

more..

Author keywords

Africa; Genomics and biobanks 101; Global health diplomacy and public health pharmacogenomics; Global personalized medicine; Neglected tropical diseases; Socio technical integration research (STIR); Vaccinomics and personalized vaccines; West African Bioethics Training Program

Indexed keywords

COMMUNICABLE DISEASE; DEGENERATIVE DISEASE; DISEASES; EDITORIAL; GENOMICS; HUMAN; NON COMMUNICABLE DISEASE; PERSONALIZED MEDICINE; PUBLIC HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84860290686     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/1875692111201010007     Document Type: Editorial

References (71)

1. Kuti FA, Ayers R. Music of Many Colors, Audio Track A. 1980.
2. Friend S. Thinking outside the genome. The Scientist 2011 (October). Available from: http://the-scientist.com/2011/10/01/ opinion-thinking-outside-the-genome/ [Accessed February 7, 2012].
3. Science Metrix. 30 years in science. Secular movements in knowledge creation. Science Metrix 2010. Available from: http:// www.science-metrix.com/30years-Paper.pdf [Accessed February 7, 2012].
4. Hotez PJ. Unleashing "civilian power": a new American diplomacy through neglected tropical disease control, elimination, research, and development. PLoS Negl Trop Dis 2011; 5(6): e1134.
5. Warnich L, Drögemöller BI, Pepper MS, et al. Pharmacogenomic research in South Africa: Lessons learned and future opportunities in the rainbow nation. Curr Pharmacogenomics Person Med 2011; 9(3): 191-207.
6. Kamal SM, Warnich L, Ferguson LR, et al. Forward Look: Tenth anniversary of the human genome sequence and 21st century postgenomics global health-A close up on Africa and women's health Curr Pharmacogenomics Person Med 2011; 9(3): 148-155.
7. Irikefe V, Vaidyanathan G, Nordling L, et al. Science in Africa: The view from the front line. Nature 2011; 474(7353): 556-9.
8. Rotimi CN. Inauguration of the African Society of Human Genetics. Nat Genet 2004; 36(6): 544.
9. Rotimi CN, Jorde LB. Ancestry and disease in the age of genomic medicine. N Engl J Med 2010; 363: 1551-8.
10. Rotimi CN. Conceptual Framework of the Human Heredity and Health in Africa. Ethics and Genomics Research in Africa (EAGER-AFRICA) Conference, Abuja, Nigeria, Nov 28-29, 2011. Available from: http://eager-africa.com/ea/slide.php [Accessed February 7, 2012].
11. Abdelhak S, Adebamowo C, Adeyemo A, et al. Harnessing genomic technologies toward improving health in Africa: opportunities and challenges. Available from: http://h3africa.org/ h3africa_whitepaper.pdf [Accessed February 7, 2012].
12. Ommer R, Wynne B, Downey R, et al. Pathways to Integration. Vancouver: Genome British Columbia GSEAC Subcommittee on Pathways to Integration, 2011. Available from: www.genomebc.ca/ index.php/download_file/view/611/910/ [Accessed on February 7, 2012].
13. Lehoux P. Moving beyond our mutual ignorance. Or, how would engaging the public benefit the personalized medicine community? Curr Pharmacogenomics Person Med 2011; 9(2): 76-9.
14. Wynne B. Lab work goes social, and vice versa: Strategising public engagement processes: commentary on: "What Happens in the Lab Does Not Stay in the Lab: Applying Midstream Modulation to Enhance Critical Reflection in the Laboratory". Sci Eng Ethics 2011 Oct 21 [Epub ahead of print].
15. Ozdemir V, Muljono DH, Pang T, et al. Asia-Pacific Health 2020 and genomics without borders: co-production of knowledge by science and society partnership for global personalized medicine. Curr Pharmacogenomics Person Med 2011; 9(1): 1-5.
16. Ozdemir V, Knoppers BM. From government to anticipatory governance. Responding to challenges set by emerging technologies and innovation. In: Governance for Health in the 21st Century. Kickbusch I. (Editor). New York: Springer 2012 (in press).
17. Landry R, Amara N, Pablos-Mendes A, et al. The knowledge-value chain: A conceptual framework for knowledge translation in health. Bull World Health Organ 2006; 84(8): 597-602.
18. Daudelin G, Lehoux P, Abelson J, et al. The integration of citizens into a science/policy network in genetics: governance arrangements and asymmetry in expertise. Health Expect 2011; 14(3): 261-71.
19. Lavis JN, Ross SE, Hurley JE, et al. Examining the role of health services research in public policymaking. Milbank Q 2002; 80: 125-54.
20. The Foresight Horizon Scanning Centre for Strategic Futures Thinking, Government of United Kingdom. Available from: http://www.bis.gov.uk/foresight/our-work/horizon-scanning-centre [Accessed February 7, 2012].
21. Ozdemir V. The moral, philosophical and legal foundations of the ethics of genomics research: towards anticipatory ethics. Ethics and Genomics Research in Africa (EAGER-AFRICA) Conference, Abuja, Nigeria, Nov 28-29, 2011. Available from: http://eagerafrica. com/ea/slide.php [Accessed February 7, 2012].
22. Hotez PJ. New antipoverty drugs, vaccines, and diagnostics: a research agenda for the US President's Global Health Initiative (GHI). PLoS Negl Trop Dis 2011; 5: e1133.
23. Ozdemir V, Pang T, Knoppers BM, et al. Vaccines of the 21st century and vaccinomics: data-enabled science meets global health to spark collective action for vaccine innovation. OMICS 2011; 15(9): 523-7.
24. Khoury MJ. Muin J. Khoury discusses the future of public health genomics and why it matters for personalized medicine and global health. Curr Pharmacogenomics Person Med 2009; 7(3): 158-63.
25. Suresh S. Moving toward global science. Science. 2011; 333(6044): 802.
26. Ozdemir V, Rosenblatt DS, Warnich L, et al. Towards an ecology of collective innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA). Curr Pharmacogenomics Person Med 2011; 9(4): 243-51.
27. Knoppers BM, Hudson TJ. The art and science of biobanking. Hum Genet 2011; 130(3): 329-32.
28. Kaye J. From single biobanks to international networks: developing e-governance. Hum Genet 2011; 130(3): 377-82.
29. Kickbusch I. Governance for health in the 21st century. Geneva: WHO Regional Office for Europe 2011. Available from: http:// www.euro.who.int/__data/assets/pdf_file/0010/148951/RC61_InfD oc6.pdf. [Accessed February 7, 2012].
30. Ozdemir V, Smith C, Bongiovanni K, et al. Policy and dataintensive scientific discovery in the beginning of the 21st century. OMICS 2011; 15(4): 221-5.
31. Fisher E. Editorial overview: public science and technology scholars: engaging whom? Sci Eng Ethics 2011; 17(4): 607-20.
32. Dandara C, Lombard Z, Du Plooy I, et al. Genetic variants in CYP (-1A2,-2C9,-2C19,-3A4 and-3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity. Pharmacogenomics 2011; 12: 1663-70.
33. Campbell MC, Tishkoff SA. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet 2008; 9: 403-33.
34. International HapMap Consortium. Integrating ethics and science in the International HapMap Project. Nat Rev Genet 2004; 5: 467-75.
35. Adebamowo CA. West African Bioethics Training Program: Raison D'etre. Afr J Med Med Sci 2007; (Suppl 36): 35-8.
36. Hotez PJ, Aksoy S. An interfaith dialogue on the neglected tropical diseases. PLoS Negl Trop Dis 2011; 5(12): e1240.
37. Hotez PJ, Kamath A. Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009; 3(8): e412.
38. Mbabazi PS, Andan O, Fitzgerald DW, et al. Examining the relationship between urogenital schistosomiasis and HIV infection. PLoS Negl Trop Dis 2011; 5(12): e1396.
39. Australian Government, Department of Health and Aging. Yellow fever fact sheets. 2010. Available from: http://www.health.gov.au/ internet/main/publishing.nsf/Content/ohp-yellow-fever-certificatefactsheet. htm [Accessed February 7, 2012].
40. Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 2010; 33(4): 530-41.
41. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366 (9503): 2112-7.
42. Justice AC. Commentary: Treated HIV infection is a chronic disease: the case against cause of death analyses. Int J Epidemiol 2010; 39 (1): 146-8.
43. Mills EJ, Rammohan A, Awofeso N. Ageing faster with AIDS in Africa. Lancet 2011; 377 (9772): 1131-3.
44. Lang AE. Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future. Nat Med 2010; 16 (11): 1223-6.
45. Alzheimer's Disease Neuroimaging Initiative. Available from: http://www.adni-info.org [Accessed February 6, 2012].
46. Parkinson's Progressive Marker Initiative. Available from: http://www.ppmi-info.org [Accessed February 6, 2012].
47. Dominantly Inherited Alzheimer Network. Available from: http://dian-info.org [Accessed February 6, 2012].
48. World Heath Organization, Advisory Committee on Health Research. Genomics and World Health. Geneva: WHO, 2002. Available from: http://whqlibdoc.who.int/hq/2002/a74580.pdf. [Accessed February 7, 2012].
49. World Heath Organization, Human Genetics Programme, Publications. Geneva: WHO, 2010. Available from: http://www. who.int/genomics/publications/en/. [Accessed February 7, 2012].
50. World Heath Organization, The Initiative on Genomics & Public Health. Geneva: WHO, 2010. Available from: http://www.who.int/ rpc/igph/en/index.html. [Accessed February 7, 2012].
51. Knoppers BM. Genomics and policymaking: from static models to complex systems? Hum Genet 2009 May; 125(4): 375-9.
52. Ozdemir V. Pharmacogenomics: Reflections on the old and new social, ethical and policy issues in postgenomics medicine. In: Pharmacogenomics in Psychiatry. Schwab M, Kaschka W, Spina E. (Eds.), Basel: S. Karger AB (2010), pp. 12-29.
53. O'Neill O. Broadening bioethics: clinical ethics, public health and global health. Nuffield Council on Bioethics Annual Lecture 2011. Available from: http://www.nuffieldbioethics.org/news/ [Accessed February 7, 2012].
54. Pullman D, Etchegary H, Gallagher K, et al. Personal privacy, public benefit, and biobanks: A conjoint analysis of policy priorities and public perceptions. 2011; Genet Med 2011; Sep 26 [Epub ahead of print].
55. Public Population Project in Genomics (P3G) 2011. Available from: http://www.p3g.org [Accessed on February 7, 2012].
56. De Vries J, Bull S, Doumbo OK, et al. Ethical issues in human genomics research in developing countries. BMC Med Ethics 2011; 12: 5.
57. Kickbush I. Global + local = glocal public health. J Epidemiol Community Health 1999; 53(8): 451-2.
58. Hill PS. Understanding global health governance as a complex adaptive system. Glob Public Health 2011; 6(6): 593-605.
59. Conley JM, Doerr AK, Vorhaus DB. Enabling responsible public genomics. Health Matrix Clevel 2010; 20(2): 325-85.
60. Dove ES. The genetic privacy carousel: A discourse on proposed genetic privacy bills and the co-evolution of law and science. Curr Pharmacogenomics Person Med 2011; 9(4): 252-63.
61. Bunge M. Social science under debate: A philosophical perspective. Toronto: University of Toronto Press 1998.
62. Fisher, Biggs S, Lindsay S, et al. Research thrives on integration of natural and social sciences. Nature 2010; 463: 1018.
63. Consortium for Science, Policy & Outcomes, College of Liberal Arts and Sciences, Arizona State University. STIR Video. Available from: http://www.cspo.org/scisip/movies/#movies [Accessed February 7, 2012].
64. Schuurbiers D. What happens in the lab: Applying midstream modulation to enhance critical reflection in the laboratory. Sci Eng Ethics 2011; 17(4): 769-88.
65. Fisher E. Ethnographic invention: Probing the capacity of laboratory decisions. NanoEthics 2007; 1(2): 155-65.
66. Conley SN. Engagement agents in the making: On the front lines of socio-technical integration. Commentary on 'Constructing productive engagement: Pre-engagement tools for emerging technologies'. Sci Eng Ethics 2011; 17(4): 715-21.
67. Kickbusch I, Buss P. Global health diplomacy and peace. Infect Dis Clin North Am 2011; 25(3): 601-10.
68. Hayden EC. Personalized cancer therapy gets closer. Nature 2009; 458: 131-2.
69. McGuire AL, Cho MK, McGuire SE, et al. Medicine. The future of personal genomics. Science 2007; 317(5845): 1687.
70. Prainsack B, Wolinsky H. Direct-to-consumer genome testing: opportunities for pharmacogenomics research? Pharmacogenomics 2010; 11(5): 651-5.
71. Guston DH. The demise of the social contract for science. Misconduct in science and the nonmodern world. In: Program in Science, Technology, and Society. Massachusetts Institute of Technology. Working paper number 19, 1992. Available from: http://web.mit.edu/STS/pubs/pdfs/MIT_STS_WorkingPaper_19_G uston_2.pdf [Accessed February 7, 2012].